Drug makers and researchers are increasingly concerned that online chatter could unravel the carefully built construct of the 'blind' clinical trial.
from WSJ.com: US Business http://ift.tt/1xwXrDz
via IFTTT
from WSJ.com: US Business http://ift.tt/1xwXrDz
via IFTTT
No comments:
Post a Comment